Cancer’s weak spots identified with CRISPR, gene editing

DNA sequence hero

A UC San Diego-led research team has put the hot gene-editing technology CRISPR/Cas9 to a novel use, finding more than 120 new leads for cancer drugs.

With the gene editing technology, large numbers of genes can be tested simultaneously for their effect on cancer, said John Paul Shen, one of the study’s lead authors.

CRISPR has made the once cumbersome process of gene editing, faster and more precise, leading to comparisons with the impact of the word processor. But in this study, Shen and colleagues turned CRISPR on its head to selectively introduce disabling errors.

In this study, researchers looked for gene pairs that exhibit “synthetic lethality.” This is when inactivating both genes kills the cells, but if one gene in the pair is active, the cells survive. So cancers driven by a synthetic lethal mutation can be killed by inactivating the other gene in the pair, leaving normal cells unharmed.

Some existing drugs work this way, such as the ovarian cancer drug olaparib, Shen said. Sold under the brand name Lynparza, the drug was approved for in December 2014 for cancers with disabling mutations in the BRCA1 or BRCA2 genes.

[Read the full study here.]

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Gene editing used to find cancer’s genetic weak spots

For more background on the Genetic Literacy Project, read GLP on Wikipedia.

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Soybean Harvest in Cupped Hands
30 years of GMO farming: Defying cynics, we’ve had larger harvests, lower costs, and $385 billion in added global farmer income
Screenshot-2026-11-17-at-12.18.09-PM
Challenging glyphosate fear-mongering: Statewide Nebraska study finds no link between weedkiller use and non-Hodgkin lymphoma
Nurturing Care Beneath the Crunchy Moms Logo
Crunchy Moms disinformation flood: Zuckerberg's Facebook has opened floodgates on measles and vaccines
Screenshot-2026-11-19-at-7.54.57-PM
European General Court sides with scientists, dismisses activist claims that glyphosate is toxically dangerous
Screenshot-2026-11-16-at-2.37.32-PM
30 years of GMO farming: Is the boom in glyphosate and glufosinate use harming the environment? Data show they’re the most sustainable choice
gut health
Health vs. hype on gut health: We are flooded by misinformation
Screenshot-2026-11-18-at-2.44.24-PM
Why should thousands of Americans die every year waiting for a kidney transplant? There’s an easy fix to this morbid reality
Stormlit Portrait Over Golden Mountains
Searching for life where no one thought to look: A renowned astrophysicist’s seemingly quixotic quest to explore Venus’s clouds
Screenshot-2026-11-19-at-7.23.23-PM
Viewpoint: After a yearlong hiatus, the U.S. Preventive Services Task Force is back in business—gutted by RFK Jr. and promoting junk science
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Gloved Hand Holding M-M-R Vaccine Vial
Viewpoint: The dangerous lie RFK Jr.-founded Children’s Health Defense is circulating to discredit one of medicine’s great breakthroughs: the MMR (measles-mumps-rubella) vaccine
measles
The grim human cost of the Trump—RFK Jr. measles-prevention failure: 16 times more cases than in 2024
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.